Financial Performance - The company's operating revenue for 2019 was CNY 18,805,181,163.52, representing a 17.26% increase from CNY 16,037,261,681.39 in 2018[20]. - The net profit attributable to shareholders of the listed company decreased by 42.02% to CNY 352,843,338.36 in 2019 from CNY 608,606,499.03 in 2018[20]. - The net cash flow from operating activities was CNY 991,005,281.30, down 29.65% from CNY 1,408,596,697.72 in the previous year[20]. - The total assets at the end of 2019 were CNY 28,634,212,470.23, an increase of 4.93% compared to CNY 27,288,722,479.43 at the end of 2018[20]. - The basic earnings per share for 2019 was CNY 0.31, a decrease of 41.51% from CNY 0.53 in 2018[22]. - The weighted average return on net assets was 4.70% in 2019, down 4.24 percentage points from 8.94% in 2018[22]. - The company reported a net profit of CNY 114,818,690.40 in Q1 2019, with a significant drop to -CNY 112,833,696.63 in Q4 2019[22]. - The net profit after deducting non-recurring gains and losses was CNY 365,589,435.71, down 35.41% from CNY 566,044,104.93 in 2018[20]. - The company reported a total revenue of 20,583,923.42 in the current period, compared to 24,111,508.86 and 25,430,084.52 in the previous periods, indicating a decline[24]. - The company achieved a revenue of RMB 18.8 billion in 2019, representing a year-on-year growth of 17.26%, with the construction decoration segment contributing RMB 17.947 billion (up 17.84%) and the healthcare segment contributing RMB 849 million (up 7.38%)[60]. - Net profit decreased by 26.91% to RMB 540 million, with a significant drop in net profit attributable to shareholders by 42.02% to RMB 353 million, primarily due to goodwill impairment of approximately RMB 440 million related to Vision[60]. Dividends and Share Buybacks - The profit distribution plan for 2019 is to distribute a cash dividend of 3 RMB per 10 shares (including tax) due to the company's share buyback[4]. - The company distributed a cash dividend of 3 RMB per 10 shares, totaling 339,900,618 RMB based on a total share capital of 1,154,050,000 shares after accounting for repurchased shares[122]. - The cash dividend for 2019 represented 117.32% of the net profit attributable to ordinary shareholders, indicating a strong return to shareholders[125]. - The company completed a share repurchase totaling 156,910,287.91 RMB, with 74,067,864.44 RMB repurchased in 2019, which is included in the cash dividend calculation[126]. - The company has a cash dividend policy that aligns with the regulations set by the China Securities Regulatory Commission, ensuring a clear standard and ratio for dividends[124]. - The company maintained a stable cash dividend payout ratio of nearly 60% over the past three years, distributing a total of approximately 339.9 million RMB in cash dividends during the reporting period[68]. Business Segments - The company operates in two main business segments: construction decoration and healthcare services, with a focus on green building systems and high-quality medical services[27]. - The construction decoration segment includes high-end curtain wall projects, interior decoration, and design services, targeting premium markets[28][30]. - The healthcare segment focuses on comprehensive ophthalmology services and third-party medical testing, with a dual-brand strategy for regional expansion[32][36]. - The construction decoration segment secured new orders worth approximately RMB 22.4 billion, a year-on-year increase of 5.78%, with curtain wall system orders reaching RMB 13.3 billion (up 20.24%)[64]. - The healthcare segment is focused on high-quality medical services, particularly in ophthalmology, and has introduced advanced medical technologies and equipment[60]. Risks and Challenges - The company may face significant risks including policy risks and market competition risks[5]. - The company faces potential risks from fluctuations in raw material prices, which could adversely affect its profitability if prices rise significantly[112]. - The company recognizes the risks associated with policy changes in the healthcare sector, which could impact its operations and is actively seeking to adapt its business model accordingly[115]. - The company acknowledges the significant impact of the COVID-19 pandemic on global economic conditions, which poses challenges to its operational performance[103]. Legal and Compliance - The company is involved in a lawsuit regarding a construction contract dispute, with a claim for 8,955,511.28 RMB in unpaid project fees currently under litigation[142]. - Another lawsuit related to the same construction contract has a claim amounting to 19,980,000 RMB for breach of contract and repair costs, which is also under litigation[142]. - The company is involved in multiple ongoing litigation cases, including a construction contract dispute with a total claim of 34,675,503.48 yuan against Wuxi World Trade Center Co., Ltd. due to delayed payments[147]. - The company has filed a lawsuit against Mingyu Real Estate Group Jilin Real Estate Development Co., Ltd. for a total of 48,910,000 yuan, seeking payment for completed engineering work[145]. - A lawsuit against Xiamen Ruxin Maternity Hospital Co., Ltd. involves a claim of 17,275,286.40 yuan for overdue payments related to an interior decoration contract[146]. - The total amount claimed in the ongoing disputes reflects significant financial implications for the company, with claims exceeding 100 million yuan across various cases[145][147]. Corporate Governance - The company has received a standard unqualified audit report from Rongcheng Accounting Firm[3]. - The company has confirmed that there are no violations of decision-making procedures for providing guarantees[5]. - The company has a robust mechanism for cash dividend decision-making, allowing minority shareholders to express their opinions effectively[124]. - The company has committed to ensuring that any new business ventures do not compete with Jianghe Group, prioritizing the interests of Jianghe Group in such cases[131]. - The company has established a long-term commitment to avoid related party transactions that could harm the interests of Jianghe Group and its subsidiaries[131]. Social Responsibility - The company actively engaged in social responsibility initiatives, donating 2 million RMB to Tsinghua University Affiliated Primary School and investing 730,800 RMB in targeted poverty alleviation efforts[69]. - The company provided financial assistance to 162 impoverished students, amounting to RMB 66,800[163]. - A total of 283 registered impoverished individuals were helped to escape poverty through the company's initiatives[163]. - The company organized job fairs in Inner Mongolia to provide employment opportunities for local graduates and disabled individuals[159]. - The company has established partnerships with local villages to support poverty alleviation efforts[159]. Innovation and Development - The company has added over 100 new patents during the reporting period, enhancing its technological capabilities in the construction decoration sector[48]. - The company has received numerous national awards, including 32 new awards in 2019, bringing the total to 199, showcasing its competitive strength in the market[64]. - The company is focusing on technological innovation and green development in the curtain wall industry, aiming for sustainable growth[99]. - The trend towards prefabricated decoration is expected to transform the interior design industry, with the company enhancing its capabilities in this area[99]. Employee and Management - The total number of common shareholders at the end of the reporting period was 25,209, an increase from 24,425 at the end of the previous month[169]. - The company has implemented a comprehensive training program for different management levels, enhancing employee skills[197]. - The total remuneration for all directors, supervisors, and senior management amounted to RMB 11,288,968.64[192]. - The company employs 3,834 technical personnel, 1,654 administrative personnel, and 503 sales personnel among its total workforce[195].

2019 年第三季度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2019 年第三季度报告 1 / 27 JANGHO 一、 重要提示 二、 公司基本情况. 三、 重要事项 四、 附录 2019 年第三季度报告 目录 2 / 27 单位：元 币种：人民币 3 / 27 2019 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘载望、主管会计工作负责人赵世东及会计机构负责人（会计主管人员）周智敏 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | --- | --- | --- | --- | |------------------------------------------------|------------------------------|------------------------ ...

Financial Performance - The company's operating revenue for the first half of the year reached CNY 7,610,737,743.99, representing a 5.49% increase compared to the same period last year [20]. - Net profit attributable to shareholders was CNY 330,054,609.48, up 4.75% year-on-year [20]. - The net profit after deducting non-recurring gains and losses was CNY 314,661,091.92, reflecting an 8.53% increase from the previous year [20]. - The company's total assets at the end of the reporting period were CNY 27,154,212,947.24, a decrease of 0.49% compared to the end of the previous year [20]. - The net assets attributable to shareholders increased to CNY 7,842,215,375.56, marking a 2.95% rise from the previous year [20]. - Basic earnings per share for the first half of the year were CNY 0.29, up 7.41% from CNY 0.27 in the same period last year [22]. - The company achieved a revenue of 7.611 billion yuan, representing a year-on-year growth of 5.49% [55]. - The construction decoration segment generated a revenue of 7.198 billion yuan, with a year-on-year increase of 5.53% [55]. - The medical health segment reported a revenue of 413 million yuan, growing by 4.88% year-on-year [55]. - The net profit reached 371 million yuan, with a net profit margin of 4.87% [55]. Risk Management - The company faces significant risks including policy risks and market competition risks [6]. - The report indicates that the company is actively managing risks associated with its operations [6]. - The company faces potential risks in the construction decoration business due to macroeconomic fluctuations and policy changes, particularly if regulations extend to public buildings [77][78]. - The company is a leading player in the domestic curtain wall industry but faces significant competition from both domestic and international firms, leading to market competition risks [79]. - The healthcare segment is influenced by local healthcare policies and regulations, which may pose risks to business operations and require adaptation to regional policies [83]. - The company is expanding its healthcare business, particularly in Australia, but faces potential risks related to local economic and political conditions [87]. Corporate Governance - The board of directors confirmed that all members attended the board meeting [4]. - There are no violations of decision-making procedures for providing guarantees to external parties [6]. - The company emphasizes the importance of accurate and complete financial reporting [3]. - The company has committed to avoiding competition with its subsidiaries and ensuring compliance with related commitments, which are effective for the duration of the shareholders' control [91]. - The company has maintained an average cash dividend ratio of nearly 60% over the past three years [60]. Research and Development - The company has added 32 new patents during the reporting period, including 15 invention patents, 16 utility model patents, and 1 design patent [43]. - Research and development expenses increased by 20.86% to ¥186,609,791.26 from ¥154,406,407.81 in the previous year [64]. - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market [95]. Market Position and Strategy - The company has a diverse portfolio including subsidiaries in various sectors such as medical and construction [14]. - The company operates in two main segments: construction decoration and healthcare services, with a focus on green building systems and high-quality medical services [26]. - The company aims to provide high-quality medical services in the ophthalmology and third-party diagnostic sectors, focusing on specialized healthcare services [32]. - The company has established a presence in over 20 countries and regions, positioning itself as a leader in the global construction and healthcare sectors [26]. - The company is positioned to capitalize on the growing demand for ophthalmology and third-party diagnostic services due to increasing health awareness and an aging population [38]. Legal Matters - The company is involved in a lawsuit with Shanghai Construction No. 2 Group Co., Ltd. and Nanchang Greenland Exhibition Real Estate Co., Ltd. regarding a contract dispute, claiming overdue payments totaling RMB 60,349,966.00 [100]. - Another lawsuit is ongoing with Changsha Huachuang Real Estate Development Co., Ltd. for overdue payments of RMB 8,955,511.28 related to a construction contract [102]. - The company’s subsidiary, Beijing Gangyuan Decoration Engineering Co., Ltd., is in litigation with Xiamen Ruxin Maternity Hospital Co., Ltd. over a contract dispute, seeking a total of RMB 17,275,286.40 for overdue payments and damages [102]. - The total amount involved in the ongoing lawsuits is RMB 86,580,785.68, with no expected additional financial losses from these cases [100][102]. Financial Position - The company's current ratio is 1.24, showing a slight increase of 0.52% compared to the previous year [137]. - The debt-to-asset ratio is 66.52%, a decrease of 0.93% from the previous year [137]. - The company has maintained a loan repayment rate of 100% [137]. - The company’s long-term credit rating is AA+ with a stable outlook, as per the latest assessment [133]. - The company has not experienced any overdue debts during the reporting period [139]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 25,206 [120]. - The largest shareholder, Beijing Jianghe Source Holdings Co., Ltd., held 315,645,200 shares, representing 27.35% of total shares [120]. - Liu Zaiwang, a significant shareholder, held 289,307,866 shares, accounting for 25.07% of total shares [120]. - The company reported no changes in share capital structure during the reporting period [119]. Social Responsibility - The company has invested RMB 150,000 in targeted poverty alleviation efforts during the reporting period [110]. - The company has actively participated in poverty alleviation activities, including donations to specific villages [110]. - The company will continue to fulfill its corporate social responsibility and focus on poverty alleviation plans based on its actual situation [113].

2019 年第一季度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2019 年第一季度报告 1 / 24 JANGHO 2019 年第一季度报告 | --- | --- | --- | --- | --- | --- | --- | |--------|-------|------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | 目录 | | | | | | | | | 一、重要提示 . | | | | | | | | 二、公司基本情况 | | | | | | | | 三、重要事项 . | | | | | | 四、附 | | 录 . | | | | | 2 / 24 2019 年第一季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人刘载望、 ...

Financial Performance - The company's operating revenue for 2018 was approximately RMB 16.04 billion, representing a 4.84% increase from RMB 15.30 billion in 2017[19]. - Net profit attributable to shareholders for 2018 was approximately RMB 608.61 million, a 30.47% increase from RMB 466.46 million in 2017[19]. - The net profit after deducting non-recurring gains and losses was approximately RMB 566.04 million, up 36.39% from RMB 415.03 million in 2017[19]. - The company's total assets at the end of 2018 were approximately RMB 27.29 billion, a 13.20% increase from RMB 24.11 billion at the end of 2017[19]. - The net assets attributable to shareholders at the end of 2018 were approximately RMB 7.62 billion, reflecting a 10.52% increase from RMB 6.89 billion at the end of 2017[19]. - Basic earnings per share for 2018 were RMB 0.53, a 32.50% increase from RMB 0.40 in 2017[21]. - The weighted average return on net assets for 2018 was 8.94%, an increase of 2.04 percentage points from 6.90% in 2017[21]. - The cash flow from operating activities for 2018 was approximately RMB 1.41 billion, a slight increase of 1.39% from RMB 1.39 billion in 2017[19]. - The company maintained a total share capital of 1.15 billion shares as of the end of 2018, unchanged from the previous year[19]. Dividend Distribution - The profit distribution plan for 2018 is to distribute a cash dividend of 3 RMB per 10 shares (including tax) due to the company's share buyback[5]. - The company distributed a cash dividend of 3.00 RMB per 10 shares for the fiscal year 2018, totaling 346,215,000 RMB, which represents 69.46% of the net profit attributable to ordinary shareholders[128]. - In 2018, the total cash dividend amount was 422,743,041.47 RMB, including the repurchased shares, with a base of 1,154,050,000 shares[130]. - The company has maintained a consistent cash dividend policy, with cash dividends of 3.00 RMB per 10 shares in both 2017 and 2018, and 1.00 RMB in 2016[129]. - The cumulative amount of shares repurchased by the company as of December 31, 2018, was 82,842,423.47 RMB, which is considered in the cash dividend calculation[129]. Business Segments - The company operates in two main business segments: construction decoration and healthcare, with a focus on green building systems and high-quality medical services[31]. - In the construction decoration segment, the company undertakes high-end projects including office buildings, hotels, and sports venues, emphasizing a competitive advantage in technology, quality, service, and cost[31]. - The healthcare segment includes ophthalmology and third-party diagnostic services, aiming to provide high-quality medical services[33]. - The company’s medical health segment includes Vision, the largest ophthalmic medical institution in Australia, recognized for its quality and risk management systems[46]. Investments and Acquisitions - The company acquired a 9.4643% stake in Shouyi Medical for 530 million yuan, enhancing its investment in the healthcare sector[43]. - The company holds a 52.5% stake in Liang Zhitian Design Group, which successfully listed on the Hong Kong Stock Exchange, raising 250.8 million HKD[43]. - Healius has acquired Jianghe Huasheng Medical, focusing on expanding its domestic pathology, third-party testing, and imaging services[47]. - The company has added over 100 patents during the reporting period and has been recognized as a leading green manufacturing enterprise in Beijing[49]. Market Outlook - The total output value of China's construction decoration industry reached 3.92 trillion yuan in 2017, with an expected increase to 4.21 trillion yuan in 2018, reflecting a compound annual growth rate of approximately 6.81% over the next five years[38]. - The healthcare industry in China exceeded 6 trillion yuan in 2018, with projections to reach 8 trillion yuan by 2020, potentially accounting for 10% of GDP[39]. - The aging population in China is expected to reach 248 million by 2020, with an aging level of 17.17%, driving growth in ophthalmic medical services[41]. - The independent medical testing and imaging sector is poised for rapid growth due to recent policy changes that enhance the role of third-party medical testing institutions[42]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Huapu Tianjian Accounting Firm[4]. - There are no non-operating fund occupations by controlling shareholders and their related parties[5]. - The company has confirmed that all board members attended the board meeting[4]. - The company has implemented changes in accounting policies to comply with new financial reporting standards, including the merging of certain financial statement items[136]. Legal and Regulatory Matters - The company has significant ongoing litigation, with frozen cash amounts totaling ¥35,467,739.77 related to various contractual disputes[86]. - The company is currently involved in multiple lawsuits, with one case involving a claim of approximately ¥18.69 million, which is under review[144]. - The company has recognized a contingent liability of approximately ¥3.9 million related to an arbitration case with Soil-Build (Pte.) Ltd[144]. - The company expects no additional financial losses from ongoing litigation, including a case with Shijiazhuang Dehong Real Estate Development involving claims of approximately ¥19.70 million[144]. Strategic Initiatives - The company plans to continue expanding its market presence and investing in new technologies and products to drive future growth[19]. - The company aims to enhance construction site quality management to deliver more premium projects, aligning with its mission to increase customer satisfaction[92]. - The company is actively pursuing the acquisition of Healius, an Australian healthcare provider, to enhance its third-party diagnostic services[117]. - The company intends to leverage overseas high-end brands and advanced management models to accelerate domestic market expansion in the medical sector[119].

江河集团 2018 年第三季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 江河集团 2018 年第三季度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2018 年第三季度报告 1 / 21 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | | | | | | | 单位：元 币种：人民币 | | | --- | --- | --- | --- | --- | --- | --- | | | 本报告期末 | | 上年度末 | | 本报告期末比上年度末增 | | | | | | | | 减(%) | | | 总资产 | 24,847,228,953.00 | | | 24,105,918,539.97 | | 3.08 | | 归属于上市公司 股东的净资产 | 6,942,328,131.68 | | | 6,892,604,664.94 | | 0.72 | | | 年初至报告期末 | | 上年初至上年报告期末 | | 比上年同期增 ...

2018 年半年度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2018 年半年度报告 1 / 184 2018 年半年度报告 重要提示 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本半年度报告涉及未来计划等前瞻性陈述，该陈述不构成公司对投资者的实质承诺，敬请投 资者注意风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况？ 否 九、 重大风险提示 本公司可能面临的重大风险主要包括政策风险、市场竞争风险等。敬请查阅本报告第四节二、 （二）可能面对的风险 十、 其他 □适用 √不适用 2 / 184 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人刘载望、主管会计工作负责人赵世东及会计机构负责人（会计主管人员）周智敏 声明：保证半年度报告中财务报告的真实、准确、完 ...

2018 年第一季度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2018 年第一季度报告 1 / 18 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 22,405,567,640.83 | 24,105,918,539.97 | | -7.05 | | 归属于上市公司 | 6,973,103,264.87 | 6,892,604,664.94 | | 1.17 | | 股东的净资产 | | | | | | | 年初至报告期末 | 上年初至上年报告期末 | 比上年同期增减(%) | | | 经营活动产生的 | -804,435,417.01 | -376,928,755.97 | | 不适用 | | 现金流量净额 | | | | | | | 年初至报告期末 | 上年初至上年报告期末 | 比上年同期增减（%） | | | 营业收入 | 3,027,955,088.69 | 2,66 ...

2017 年年度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2017 年年度报告 1 / 229 2017 年年度报告 重要提示 三、 华普天健会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、 公司负责人刘载望、主管会计工作负责人赵世东及会计机构负责人（会计主管人员）周智敏 声明：保证年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 2017 年度利润分配预案为：以公司现有总股本 1,154,050,000 股为基数，按每 10 股派发现 金红利 3.00 元（含税）共分配股利 346,215,000 元。 六、 前瞻性陈述的风险声明 √适用 □不适用 本年度报告涉及未来计划等前瞻性陈述，该陈述不构成公司对投资者的实质承诺，敬请投资 者注意风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况？ 否 九、 重大风险提示 本公司可能面临的重大风险主要包括政策风险、市场竞争风险等。敬请查阅本报告第二节三、 （四）可能面对的风险 十、 其他 □适用 ...

江河集团 2017 年第三季度报告 公司代码：601886 公司简称：江河集团 江河创建集团股份有限公司 2017 年第三季度报告 1 / 21 | 一、重要提示 | 3 | | --- | --- | | 二、公司基本情况 | 3 | | 三、重要事项 | 5 | | 四、附录 | 9 | 江河集团 2017 年第三季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 | | 本报告期末 | | 上年度末 | | 本报告期末比上年度 | | | --- | --- | --- | --- | --- | --- | --- | | | | | | | 末增减(%) | | | 总资产 | 24,109,646,898.28 | | 25,350,807,831.39 | | | -4.90 | | 归属于上市公司股东 | 6,699,873,740.31 | | 6,681,798,603.19 | | | 0.27 | | 的净资产 | | | | | | | | | 年初至报告期末 | | 上年初至上年报告期末 | | 比上年同期增减(%) | | | | （1-9 | 月） | （1-9 ...